# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-003167
Filing Date
2022-11-10
Accepted
2022-11-10 17:03:14
Documents
76
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tmb-20220930x10q.htm iXBRL | 10-Q | 1942037
2 | EX-31.1 | tmb-20220930xex31d1.htm | EX-31.1 | 14329
3 | EX-32.1 | tmb-20220930xex32d1.htm | EX-32.1 | 7289
4 | GRAPHIC | tmb-20220930x10q001.jpg | GRAPHIC | 51952
| Complete submission text file | 0001410578-22-003167.txt |  | 8330736

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | tmb-20220930.xsd | EX-101.SCH | 58498
6 | EX-101.CAL | tmb-20220930_cal.xml | EX-101.CAL | 49450
7 | EX-101.DEF | tmb-20220930_def.xml | EX-101.DEF | 299782
8 | EX-101.LAB | tmb-20220930_lab.xml | EX-101.LAB | 448969
9 | EX-101.PRE | tmb-20220930_pre.xml | EX-101.PRE | 425123
70 | EXTRACTED XBRL INSTANCE DOCUMENT | tmb-20220930x10q_htm.xml | XML | 1409143

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 221378353
SIC: 2834 Pharmaceutical Preparations